Millennium Pharmaceuticals today is expected to announce it is halting a clinical trial of its drug Velcade as it already has been proven effective in slowing the progression of multiple myeloma. Results were not expected before 2005, but a panel of monitors said Velcade had significantly delayed worsening of the cancer in comparison with an alternative treatment.

Full Story:

Related Summaries